ICI Impact on COVID-19 Severity Modest at Best.
Cancer Discov
; 10(10): 1432-1433, 2020 10.
Article
in English
| MEDLINE | ID: covidwho-723947
ABSTRACT
Several retrospective studies have examined whether patients with cancer who develop COVID-19 may be at risk of more severe viral disease if their therapy includes immune checkpoint inhibition. Although the data are not uniform, for now, halting or modifying cancer treatment decisions is unnecessary; meanwhile, vigilance with testing for COVID-19 in this population is recommended.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Pandemics
/
Programmed Cell Death 1 Receptor
/
Betacoronavirus
/
Antineoplastic Agents, Immunological
/
Neoplasms
Type of study:
Diagnostic study
/
Experimental Studies
/
Observational study
/
Prognostic study
Limits:
Aged
/
Humans
Language:
English
Journal:
Cancer Discov
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS